Nasdaq

Advantis Corp. Increased Revenue Over Eight Fold in 2017, Expects Revenue to Rise

16-04-2018

NEWPORT BEACH, CA , April 16, 2018 (GLOBE NEWSWIRE) -- ADVANTIS CORPORATION (OTC PINK: ADVT) released its annual financial report, revealing the revenue increase of a company on the rise. 2017 revenue was $406,000 vs. $46,000 in 2016, when the company just started building its Amster-Can division. The company reported 4th quarter revenue of $160,560, a company record produced during a time of leadership transition. Advantis CEO, Darren Cherry, says the company should continue to see quarterly revenue records, “for the foreseeable future.”

When Advantis began its partnership with N2Pack to create its Amster-Can packaging solutions in 2016, the scant company revenue was derived from an array of cannabis and pain related products. When the company began marketing Amster-Can and picking up clients primarily through referrals, the fresh storage solution began gaining significant traction in the marketplace. As these relationships build, the trust, quality and service Advantis imbues allows them to market their proprietary products, as well as cross market products for its stronger relationships. The company has been growing its revenue quarter over quarter since it began this strategy, and it shows in their latest financial update. According to Cherry, “Wow. I am blessed to have inherited such an amazing, innovative and growing company to pilot. I anticipate we will continually increase volume, revenue, as well as our relationships and partners. Last year we had ignition... this year, we blast off.”

Cherry says that the first quarter will be another company revenue record, and he expects the same for at least the remainder of this year. “We have a great team, here at Advantis,” Cherry explained. “We are all focused in the right direction and acutely aware of how our efforts impact the bottom line. Amster-Can has truly been the key to our relationship building ability in this industry. It opens the door to roll out innovative proprietary products, and synergistic cooperative arrangements that allow us to make big leaps, like what we’re able to do with the upcoming Pet Division. With the genius of Dr. Geoff working with us to develop the product formulae and open the door to a multi-billion dollar pet market... serving as another example of how important the right relationships are to our success as a company. I’m excited about the opportunities we have in this space, and it is these relationships that allow us to generate revenue by doing what we love.” Cherry reiterated how important their clients and partners are to him, and added, “I’m looking forward to when I’m able to make some major announcements about the growth of some of these relationships.”

Prospects for Advantis are bright. The company recently expanded their reach into several other states, with key relationships being established in Nevada and Oregon. Oregon is employing a canning machine full-time, and expects further growth in demand. “The relationship with Players Network is ramping up, and we’ve moved our production facility to a central delivery area. Nevada is coming online with built in demand, and future plans are in place for further expansion with them. We have a couple large agreements nearing the finish line; We expect a significant late-year revenue boost from the upcoming Pet Division; And we are poised to significantly increase production capacity for Amster-Can. If last year was nearly half a million revenue, I can confidently state that revenue will be in the millions this year.” Cherry concluded.

Advantis wishes to thank Investors Hangout for mentioning the company in their podcast. 

Links to Advantis websites can be found at advantiscorp.comrosin6.comelixicure.com, and amstercan.com

About Advantis Corporation

Advantis Corporation (ADVT) focuses on the development of innovative products that supply the medical, research, and pharmaceutical industries. The company additionally establishes partnerships with businesses that develop and sell proprietary pain management, and consumer products and services. 

Forward Looking Statements: This news release contains forward-looking statements made by ADVANTIS CORPORATION. All such statements included in this press release, other than statements of historical fact, are forward-looking statements. Although management believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Actual results may differ materially from those indicated by these statements. The following risk factors, among others, could cause actual results to differ materially from those described in any forward- looking statements. These risks and uncertainties include, but are not limited to, economic conditions, changes in the law or regulations, demand for products of the Company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward looking statements. Forward- looking statements are typically identified by the words: believe, expect, anticipate, intend, estimate, and similar expressions or which by their nature refer to future events. The Company is not entitled to rely on the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 because it is not registered under either Act. 

CONTACT: For further information, contact:
Media Relations Contact Name: Woo Kim, Director
Organization: Advantis Corporation
Phone: 949-354-3585
Address: 1048 Irvine Ave. #900 Newport Beach, CA 92660
E-mail: info@advantiscorp.com